Prevalence of hypercalcaemia in normal and in hospital populations

Danish Medical Bulletin

Volumn 45, Issue 4, 1998, Pages 436-439

  Frølich, Anne ^a,b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA BASE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCALCEMIA; HYPERPARATHYROIDISM; POPULATION RESEARCH; PREVALENCE; SCANDINAVIA;

HOSPITALS; HUMANS; HYPERCALCEMIA; PREVALENCE;

EID: 0031683959     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bajorunas DR. Clinical manifestations of cancer-related hypercalcaemia. Semin Oncol 1990; 17 (Suppl 5): 16-25.
2. Burt ME, Brennan MF. Incidence of hypercalcaemia and malignant neoplasm. Arch Surg 1990; 115: 704-7.
3. Amott RD, Melick RA. Hypercalcaemia in an adult hospital population. Med J Aust 1979; I: 206-7.
4. Blind E, Raue K, Zisterer A, Kohl B, Ziegler R. Epidemiologie der Hypercalcämie. Bedeutung der Bestimmung des intakten Parathormons für die Differentialdiagnose. Dtsch Med Wochenschr 1990;115:1739-45.
5. Boonstra CE, Jackson CE. The clinical value of routine serum calcium analysis. Ann Intern Med 1962; 57: 963-9.
6. Boonstra CK, Jackson CE. Hyperparathyroidism detected by routine serum calcium analysis. Ann Intern Med 1965; 63: 468-74.
7. Diamond TM, Botha JR, Vermaak WJH, Kalk WJ. Hypercalcaemia in the Johannesburg Hospital. Differential diagnosis and physician awareness of primary hyperparathyroidism. S Afr Med J 1987; 72: 113-5.
8. Dent DM, Miller JL, Klaff L, Barron J. The incidence and causes of hypercalcaemia. Postgrad Med J 1987; 63: 745-50.
9. Frølich A, Nielsen BF, Conradsen K, McNair P. Filtering clinically significant hypercalcaemia from non-significant hypercalcaemia at the laboratory level. Scand J Clin Lab Invest 1993; 53: 215-23.
10. Frølich A, Nielsen BF, Conradscn K, McNair P, Transbøl I. Within-centre evaluation of hypercalcaemia discriminant functions 5 years after their development. Int J Biomed Comput 1996; 40: 235-40.
11. Frølich A. Combined reports on serum calcium and discriminant functions increase the diagnostic rate of hypercalcaemia. Scand J Clin Lab Invest 1997; 57: 725-30.
12. Frølich A, Nielsen BF. Transfer of hypercalcemia discriminant functions between local hospitals. Int J Biomed Comput 1996; 41: 167-73.
13. Grero PS, Hodkinson HM. Hypercalcaemia in elderly hospital in-patients: value of discriminant analysis in differential diagnosis. Age Ageing 1977; 6: 14-20.
14. McLellan G, Baird CW, Path MC, Melick R. Hypercalcaemia in an Australian hospital adult population. Med J Aust 1968; 11: 354-6.
15. Niederle B, Stamm I., Langle K, Schubert E, Woloszczuk W, Prager R. Primary hyperparathyroidism in Austria: results of an 8-year prospective study. World J Surg 1992; 16: 777-83.
16. Rajathurai A, Cove-Smith R. Hypercalcaemia in Cleveland: a hospitalbased survey. J R Soc Med 1984; 77: 742-6.
17. Biermann WA, Cantor RI, Fellin FM, Jakobowski J, Hopkins L, Newbold RC. An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone. Bone 1991; 12 (Suppl 1): S37-42.
18. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 1996; 334: 488-93.
19. Parfitt AM, Rao DS, Kleerekoper M. Asymptomatic primary hyper-parathyroidism discovered by multichannel biomedical screening: clinical course and considerations bearing on the need for surgical intervallion. J Bone Miner Res 1991; 6(Suppl 2): S97-101.
20. Heath III H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism Incidence, morbidity, and potential economic impact in a community. N. Engl J Med 1980; 302: 189-93.
21. Parfitt AM, Willgoss D, Jacobi J, Lloyd HM. Cell kinetics in parathyroid adenomas: evidence for decline in rates of cell birth and tumor growth assuming clonal origin. Clin Endocrinol 1991; 35: 151-7.
22. Kleerekopcr M, Bilezkian JP. A cure in search of a disease: parathyroid ectomy for nontraditional features of primary hyperparathyroidism [Editorial]. Am J Med 1995; 96: 99-100.
23. Kairaluoma MV, Mäkäräinen H, Kellosalo J, Haukipuro K, Kairaluom MI. Results of surgery in primary hyperparathyroidism. Ann Chir Gynaecol 1992; 81: 309-15
24. Hedbäck G, Oden A. Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery. Eur J Clin Invest 1995; 25: 48-52.
25. Frølich A, McNair P, Transbøl I. Awareness of hypercalcaemia in a hospital population? Scand J Clin Lab Invest 1991; 51: 37-41.
26. Link K, Centor R, Buchsbaum D, Winterspoon J. Why physicians do pursue abnormal laboratory tests: an investigation of hypercalcemia in the follow-up of abnormal results. Hum Pathol 1984; 15: 75-8.
27. Nussbaum S. Immunometric assays of parathyrin in the diagnosis of hypercalcemia individuals. Clin Chem 1991; 37: 142-3.
28. Christensson T, Hellström K, Wengle B, Alveryd A, Wikland B. Prevalence of hypercalcaemia in a health screening in Stockholm. Acta Mat Scand 1976; 200: 131-7.
29. Lindstedt G, Nyström E, Lundberg PA, Johansson E, Eggertsen A. Screening of an elderly population in primary care for primary hyper-parathyroidism. Scand J Prim Health Care 1992; 10: 192-7.
30. Palmer M, Jacobsson S, Åkerström G, Ljunghall S. Prevalence of hyper-calcaemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest 1988; 18: 39-46.
31. Sherman SS, Hollis BW, Tobin JD. Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J Endocrinol Metab 1990; 71: 405-13.
32. Faulkner WR, Demers LM. Importance of age-dependent reference ues in biochemical testing: are we including the elderly population? J Chem 1994; 40: 855-6.
33. Frølich A, Nielsen BF, Nielsen J, Conradsen K, McNair P. Do local hospitals meet the analytical goals for the use of common reference vals? Scand J Clin Lab Invest 1994; 54: 169-76.
34. Ladenson JH, Lewis JW, Boyd JC. Failure of total calcium corr protein, albumin, and pH to correctly assess free calcium status Endocrinol Metab 1978; 46: 986-93.
35. Thode J, Juul-Jßrgensen B, Bhathis HM, Kjærulf-Nielsen M, Bartels PD, Fogh-Andersen N et al. Comparison of serum total calcium, albumin-corrected total calcium, and ionized calcium in 1213 patients with suspected calcium disorders. Scand J Clin Lab Invest 1989; 49: 217-23.
36. Broadus AE, Horst RL, Littledike ET, Mahaffey JE, Rasmussen H. Primary hyperparathyroidism with interminent hypercalcemia: serial observations and simple diagnosis by means of an oral calcium tolerance test. Clin Endocrinol 1980; 12: 225-35.
37. Nielsen HK, Laurberg P, Brixen K, Mosekilde L. Relations between diurnal variations in serum osteocalcin, cortisol, parathyroid hormone, and ionized calcium in normal individuals. Acta Endocrinol 1991; 124: 391-8.
38. Greaves I, Grant AJ, Heath DA, Michael J, Adu D. Hypercalcaemia:changing causes over the past 10 years. BMJ 1992; 304: 1284-4.
39. Forster J, Querusio L, Burchard KW, Gann DS. Hypercalcaemia in critically ill surgical patients. Ann Surg 1985; 202: 512-8.